Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.200
-0.010 (-0.83%)
Apr 28, 2026, 1:42 PM EDT - Market open
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $13.94 million as of April 28, 2026. Its market cap has increased by 76.82% in one year.
Market Cap
13.94M
Enterprise Value
-6.97M
1-Year Change
76.82%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $16.22M to $13.94M, a decrease of -14.06%. That is a compound annual growth rate of -1.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 14.06M | 24.37% |
| Dec 31, 2025 | 11.30M | 262.46% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 15.51M |
| Hoth Therapeutics | 15.49M |
| IN8bio | 14.77M |
| Soligenix | 14.33M |
| Jupiter Neurosciences | 14.15M |
| Moleculin Biotech | 13.55M |
| CDT Equity | 13.36M |
| Intensity Therapeutics | 13.34M |